Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Pathways CEO Interviewed by StreetSideInvestor.


Business Editors

VALPARAISO, Ind.--(BUSINESS WIRE)--Aug. 4, 2000

Mr. Robert Towarnicki, President and Chief Executive Officer of Cell Pathways Holdings (Nasdaq:CLPA CLPA CC-Link Partner Association
CLPA Club Loisirs et Plein Air (Montpellier, France)
CLPA Child Labour Programme of Action (national plan to eliminate child labour in South Africa) 
) is featured as one of the premier executives interviewed on StreetSideInvestor's Executives' Corner, which can be accessed at www.streetsideinvestor.com. The interview discusses Cell Pathways' innovation, products, and growth. Executive's Corner has interviewed executives in different sectors such as About.com (Nasdaq:BOUT), Immunex Corp (Nasdaq:IMNX), MicroStrategy (Nasdaq:MSTR MSTR Microstrategy, Inc (stock symbol)
MSTR Master
MSTR Minneapolis and St. Louis (railroad)
MSTR Master Mode
), and Xcelera.com (AMEX AMEX

See: American Stock Exchange
:XLA XLA X-Linked Agammaglobulinemia
XLA Excel Airways (British airline)
XLA Microsoft Excel Addin
XLA Xbox Live Arcade (gaming)
XLA X-Band Limiter Attenuator
XLA Excel Add-in
XLA Xlib Archive
).

About Cell Pathways Holdings.

Cell Pathways (Nasdaq:CLPA) is a pharmaceutical company focused on the research, development and commercialization of products to prevent cancer and to treat cancer. The Company's technology is based upon its discovery of a novel mechanism, the SAANDs technology, that it believes, based on its research, can be targeted to induce selective apoptosis, or programmed cell death pro·grammed cell death
n.
See apoptosis.



programmed cell death

proposed system of cell death, often including poly(ADP)-ribosylation, ensures that a cell will not survive if it is so badly damaged that its recovery would harm the
, in precancerous precancerous /pre·can·cer·ous/ (-kan´ser-us) pertaining to a pathologic process that tends to become malignant.

pre·can·cer·ous
adj.
 and cancerous cells without affecting normal cells.

About StreetSideInvestor, Inc.

StreetSideInvestor, Inc. is a leading financial content provider committed to providing in-depth cutting edge research to the investing public. The company's English site, located at http://www.streetsideinvestor.com, offers commentary from an experienced team of financial journalists and provides innovative features such as the Insider Wire, StreetSide Insider, Executive's Corner, Insider Wire, and Head-to-Head. All information on StreetSideInvestor is completely free of charge.

For more information on StreetSideInvestor Inc. visit http://www.streetsideinvestor.com
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 4, 2000
Words:227
Previous Article:Plantagenet Capital Leads Second Round Financing for Virtual Purchase Card.
Next Article:CIBC World Markets Analyst to Interview On RadioWallStreet.com.
Topics:



Related Articles
New clue hints at how anthrax kills.
ISIS Pharmaceuticals CEO Interviewed by StreetSideInvestor.
Epitope CEO Interviewed by StreetSideInvestor.
ARIAD Pharmaceuticals CEO Interviewed by StreetSideInvestor.
SCLN CEO Interviewed by StreetSideInvestor.
CANCER CELLS SHOW HIGH ENZYME LEVEL.
Corn lily compound stops cancer in mice. (Flower Power).
XENCOR LICENSES CHRONOS' ACE TO GENERATE PDA CELL LINES.
The fat track: signals between cells keep creatures lean.
Different pollutants show same impact.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles